Stephen J. Kanes
2017
In 2017, Stephen J. Kanes earned a total compensation of $2M as Chief Medical Officer at Sage Therapeutics, a 104% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,045 |
|---|---|
| Option Awards | $1,324,289 |
| Salary | $426,676 |
| Other | $5,607 |
| Total | $1,971,617 |
Kanes received $1.3M in option awards, accounting for 67% of the total pay in 2017.
Kanes also received $215K in non-equity incentive plan, $426.7K in salary and $5.6K in other compensation.
Rankings
In 2017, Stephen J. Kanes' compensation ranked 5,569th out of 14,666 executives tracked by ExecPay. In other words, Kanes earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,569 out of 14,666 | 62nd |
Division Manufacturing | 2,015 out of 5,770 | 65th |
Major group Chemicals And Allied Products | 620 out of 2,074 | 70th |
Industry group Drugs | 476 out of 1,730 | 73rd |
Industry Pharmaceutical Preparations | 373 out of 1,329 | 72nd |
Source: SEC filing on April 27, 2018.
Kanes' colleagues
We found four more compensation records of executives who worked with Stephen J. Kanes at Sage Therapeutics in 2017.